Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • bicalutamide cas 90357-06-5

nóv . 02, 2024 03:41 Back to list

bicalutamide cas 90357-06-5



Bicalutamide A Comprehensive Overview


Bicalutamide, a nonsteroidal antiandrogen, is primarily used in the treatment of prostate cancer. This medication, with the CAS (Chemical Abstracts Service) number 90357-06-5, works by blocking the action of androgens, such as testosterone, which can promote the growth of prostate cancer cells. It is commonly prescribed as part of combination therapy, often used in conjunction with other treatments like castration.


Mechanism of Action


Bicalutamide exhibits its therapeutic effects by binding to androgen receptors in the body. By doing so, it inhibits the natural androgens from attaching to these receptors, effectively blocking their action. This prevents the stimulation of growth in androgen-sensitive tissues, including the prostate gland. The result is a decrease in tumor size and a potential reduction in the progression of cancer.


Clinical Usage


The primary indication for bicalutamide is in the treatment of advanced prostate cancer, particularly in patients who are undergoing castration therapy. It is often used as a first-line treatment or to manage prostate cancer that has metastasized. Bicalutamide is also sometimes prescribed for conditions related to hyperandrogenism and other effects of excess androgen levels.


bicalutamide cas 90357-06-5

bicalutamide cas 90357-06-5

Dosage and Administration

Bicalutamide is typically administered orally, with a standard dosage of 50 mg taken once daily. Dosage adjustments may be necessary based on patient response and the severity of side effects. It is essential for patients to adhere to their prescribed regimen for optimal therapeutic outcomes. Patients are advised to consult their healthcare provider for guidance tailored to their specific condition.


Side Effects


While bicalutamide is generally well-tolerated, it is not without its side effects. Common adverse reactions include hot flashes, gastrointestinal disturbances, fatigue, and gynecomastia (enlargement of breast tissue in men). More severe side effects may include liver dysfunction, so regular monitoring of liver function tests is recommended during treatment.


Conclusion


In conclusion, bicalutamide is a critical component in the management of prostate cancer, contributing to improved patient outcomes through its unique mechanism of action. Though side effects may arise, the benefits of effectively targeting androgen receptors make it a valuable tool in oncological therapy. As research continues, the scope of bicalutamide's applications may expand, reinforcing its role in the ongoing battle against prostate cancer. For any individual considering treatment with bicalutamide, a comprehensive discussion with a healthcare professional is imperative to navigate the associated risks and benefits.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
is_ISIcelandic
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu is_ISIcelandic